Stockreport

INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer’s Webinar

INmune Bio Inc. - Common stock  (INMB) 
PDF Boca Raton, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a late-stage biotechnology company focused on inflammati [Read more]